Dec 10, 2024 12:00
OKUR - OnKure Therapeutics, Inc. Class A Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 2.89 0.07 (2.42%) | --- | --- | --- | --- | 0.07 (2.42%) | --- | --- |
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -1.14
- Diluted EPS:
- -1.14
- Basic P/E:
- -2.5965
- Diluted P/E:
- -2.5965
- RSI(14) 1m:
- 55.56
- VWAP:
- 2.95
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|